Generate real-world evidence on biomarker testing patterns, equity, and outcomes using EHR-derived oncology data to drive solutions and action for clients.
Key Activities
Panoramic database: 750K+ breast cancer patients; 26K+ ovarian cancer patients; longitudinal EHR data. Key biomarker work: racial/ethnic inequities in biomarker testing for HR+/HER2- mBC (ASCO 2025 abstract). AI-based PD-L1 biomarker data extraction from EHRs. Flatiron-Foundation Medicine Prospective Clinico-Genomic (PCG) study for community oncology biomarker research.